MANDELAMINE Trademark

Trademark Overview

On Wednesday, February 21, 2018, a trademark application was filed for MANDELAMINE with the United States Patent and Trademark Office. The USPTO has given the MANDELAMINE trademark a serial number of 87805506. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 13, 2022. This trademark is owned by Edenbridge Pharmaceuticals, LLC. The MANDELAMINE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibacterial pharmaceuticals; Antibiotic tablets; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of frequently recurring urinary tract infections when long-term therapy is considered necessary; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for prophylactic or suppressive treatment of frequently recurring urinary tract infections; Pharmaceuticals, namely, anti-infectives; Urinary tract disinfectants
mandelamine

General Information

Serial Number87805506
Word MarkMANDELAMINE
Filing DateWednesday, February 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 13, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements

Goods and ServicesAnti-infectives; Antibacterial pharmaceuticals; Antibiotic tablets; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of frequently recurring urinary tract infections when long-term therapy is considered necessary; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for prophylactic or suppressive treatment of frequently recurring urinary tract infections; Pharmaceuticals, namely, anti-infectives; Urinary tract disinfectants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEdenbridge Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameEdenbridge Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, June 13, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 13, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2021SOU EXTENSION 5 GRANTED
Wednesday, October 27, 2021SOU EXTENSION 5 FILED
Tuesday, November 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 28, 2021SOU EXTENSION 4 GRANTED
Wednesday, April 28, 2021SOU EXTENSION 4 FILED
Wednesday, April 28, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 29, 2020SOU EXTENSION 3 GRANTED
Thursday, October 29, 2020SOU EXTENSION 3 FILED
Thursday, October 29, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 7, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, May 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 30, 2020SOU EXTENSION 2 GRANTED
Thursday, April 30, 2020SOU EXTENSION 2 FILED
Thursday, April 30, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2019SOU EXTENSION 1 GRANTED
Friday, November 1, 2019SOU EXTENSION 1 FILED
Friday, November 1, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, June 26, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 6, 2019ASSIGNED TO LIE
Wednesday, January 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 6, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 8, 2018NON-FINAL ACTION E-MAILED
Friday, June 8, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 5, 2018ASSIGNED TO EXAMINER
Tuesday, February 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 24, 2018NEW APPLICATION ENTERED

Related Keywords

mandelamine pharmaceutical preparations tract urinary frequently recurring treatment anti infectives pharmaceuticals